Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study-authors' response

Journal of Antimicrobial Chemotherapy

Volumn 70, Issue 10, 2015, Pages 2922-

  Tumbarello, Mario ^a   Viale, Pierluigi ^b   Bassetti, Matteo ^c   De Rosa, Francesco Giuseppe ^d,e   Spanu, Teresa ^a   Viscoli, Claudio ^f  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c S Maria Hospital   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

^e AMEDEO DI SAVOIA HOSPITAL   (Italy)

^f UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CARBAPENEM; CARBAPENEM DERIVATIVE; COLISTIN; GENTAMICIN; MEROPENEM; TIGECYCLINE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BROTH DILUTION; DISEASE SEVERITY; DRUG EFFICACY; EPSILOMETER TEST; HUMAN; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; KPC PRODUCING KLEBSIELLA PNEUMONIAE; LABORATORY TEST; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; MORTALITY; MULTICENTER STUDY (TOPIC); MULTIDRUG RESISTANCE; RISK FACTOR; TREATMENT DURATION; DRUG EFFECTS; ENZYMOLOGY; FEMALE; KLEBSIELLA INFECTIONS; MALE; SECRETION (PROCESS);

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; FEMALE; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE;

EID: 84943751309     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkv200     Document Type: Article

References (7)

1. Tascini C, Viaggi B, Menichetti F. Comment on: Infections caused by KPCproducing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study. J Antimicrob Chemother 2015; doi:10.1093/jac/dkv168.
2. Tumbarello M, Trecarichi EM, De Rosa FG et al. Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study. J Antimicrob Chemother 2015; 70: 2133-43.
3. Arena F, Giani T, Vaggelli G et al. Accuracy of different methods for susceptibility testing of gentamicin with KPC carbapenemase-producing Klebsiella pneumoniae. Diagn Microbiol Infect Dis 2015; 81: 132-4.
4. Bobenchik AM, Deak E, Hindler JA et al. Performance of Vitek 2 for antimicrobial susceptibility testing of Enterobacteriaceae with Vitek 2 (2009 FDA) and 2014 CLSI breakpoints. J Clin Microbiol 2015; 53: 816-23.
5. Marchaim D, Pogue JM, Tzuman O et al. Major variation in MICs of tigecycline in Gram-negative bacilli as a function of testing method. J Clin Microbiol 2014; 52: 1617-21.
6. Hindler JA, Humphries RM. Colistin MICvariability by method for contemporary clinical isolates of multidrug-resistant Gram-negative bacilli. J Clin Microbiol 2013; 51: 1678-84.
7. Daikos GL, Tsaousi S, Tzouvelekis LS et al. Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems. Antimicrob Agents Chemother 2014; 58: 2322-8.